VentriNaya
PrivateLast Round
Accelerator
Nov 11, 2025
Company Overview
VentriNaya is a biotechnology company developing scalable, off-the-shelf regenerative gene and cell therapy platforms to treat cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VentriNaya Comps
Public and private peers based on sector, stage, and business model.
VentriNaya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 11, 2025 |
VentriNaya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cure by Deerfield | Accelerator |
| Qatar Development Bank | Accelerator |
| Qatar Investment Authority | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Raised an Accelerator round with Qatar Investment Authority and Cure by Deerfield.
VentriNaya Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VentriNaya's valuation, stock price, and market status.
